Important Safety Considerations and Evidence Limitations While preliminary findings are encouraging, GLP-1 medications like compounded semaglutide injections should not replace evidence-based smoking cessation therapies such as nicotine replacement therapy, prescription medications (varenicline or bupropion), or behavioral counseling
A combination product of lixisenatide with insulin glargine (Lantus) is available as SOLIQUA [soh LEE kwa]
We verify insurance, manage prior authorizations, and handle documentation, letting you focus on your wellness
Appetite scores, rated on a 1 to 10 scale at consistent times of day, reveal whether your GLP-1 and GIP receptor activation is adequate
Virginias obesity rates have trended upward over the past decade, with significant variation between the densely populated Northern Virginia suburbs and more rural regions of the state like Southwest Virginia and the Shenandoah Valley
It provides a higher percentage of weight loss compared with similar agents, which may be attributed to its unique mechanism of action